Cargando…
The Choice of Local Treatment Modalities for Patients with Brain Metastases from Digestive Cancers
BACKGROUND: Brain metastases (BMs) from digestive cancers are rare; therefore, no optimal treatment modality has been defined. METHODS: We retrospectively reviewed the clinical data of 68257 patients with digestive cancers. Propensity score matching (PSM) was used to balance patient backgrounds betw...
Autores principales: | Dong, Jun, Wu, Liyan, Wang, Fang, Huang, Jinsheng, Hu, Pili, Zhang, Bei, Xia, Liang-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907058/ https://www.ncbi.nlm.nih.gov/pubmed/31871456 http://dx.doi.org/10.1155/2019/1568465 |
Ejemplares similares
-
DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices
por: Buka, Richard J., et al.
Publicado: (2022) -
Choice of radiotherapy modality for the combined treatment of non-small cell lung cancer with brain metastases: whole-brain radiation therapy with simultaneous integrated boost or stereotactic radiosurgery
por: Dong, Xiaotao, et al.
Publicado: (2023) -
An exploratory study of CT-guided percutaneous radiofrequency ablation for stage I thymoma
por: Dong, Jun, et al.
Publicado: (2019) -
Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2021) -
Choice of the Dialysis Modality: Practical Considerations
por: Torreggiani, Massimo, et al.
Publicado: (2023)